Nonclassical congenital adrenal hyperplasia carriers have a higher prevalence of polycystic ovarian syndrome than the general population
The prevalence of polycystic ovarian syndrome (PCOS) in the general population as diagnosed by the Rotterdam criteria ranges from 8-13%1. Patients with nonclassical congenital adrenal hyperplasia (NCCAH) often meet clinical criteria for polycystic ovarian syndrome (PCOS); however, it is not known if the same is true of women who are heterozygous for CYP21A2 gene mutations.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: K.S. Merriam, S.A. Neal, S.J. Morin, A.W. Tiegs, J. Landis, R.T. Scott, M.D. Werner Tags: Poster Presentation Source Type: research
More News: Congenital Adrenal Hyperplasia | Genetics | Ovaries | Polycystic Ovary Syndrome | Reproduction Medicine | Women